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Abstract
Background: Immunosenescence is associated with several changes in adaptive and innate immune cells. Altered
cytokine production is among the most prominent of these changes. The impact of age-related alterations on cytokine
global profiles produced by distinct populations of leukocytes from healthy Brazilian individuals was studied. We
analysed frequencies of cytokine-producing lymphocytes and innate immune cells from individuals at several ages
spanning a lifetime period (0–85 years).
Results: Healthy adult individuals presented a balanced profile suggestive of a mature immune system with equal
contributions of both innate and adaptive immunity and of both categories of cytokines (inflammatory and regulatory).
In healthy newborns and elderly, innate immune cells, especially neutrophils and NK-cells, contributed the most to a
balanced profile of cytokines.
Conclusions: Our results support the hypothesis that ageing is not associated with a progressive pro-inflammatory
cytokine production by all leukocytes but rather with distinct fluctuations in the frequency of cytokine-producing cells
throughout life.
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Background
In the past decade, a new approach to the study of
ageing emerged from the data collected from centenar-
ians. The concept of successful or healthy ageing comes
from these studies and it eliminated the confusion be-
tween ageing and age-related disorders. According to
these studies, immunosenescence does not involve a
simple unidirectional decline in all functions, but rather
a remodeling of biological systems during the ageing
process. In this sense, many immunological activities are
well preserved in the healthy elderly and they may com-
pensate for other functions that are impaired [1–3].
Ageing is associated with several alterations in the
phenotype, repertoire and activation status of leukocytes
as well as in the cytokine profile produced by these cells.
This complex age-related remodeling of the immune
system is responsible for the profound changes within
the cytokine network [3–8]. Cytokines are a key compo-
nent in the communication among immune cells and
they are responsible for differentiation, proliferation and
survival of lymphoid cells, playing an important role in
immune responses and inflammation. Age-related
changes in the cytokine network is responsible for a
chronic proinflammatory status, known as “inflammage-
ing” [3, 5]. Inflammageing has been described as a
combination of dysfunctional immunity with a state of
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low grade chronic inflammation and it has been consid-
ered as an universal phenomenon associated with frailty
and morbidity in the elderly [3, 8–11]. This progressive
increase in pro-inflammatory status is one of the major
characteristics of immunosenescence [12–14].
Several ageing-associated immunological alterations
have been already described in medical literature, mostly
in the T-cell compartment. They include involution of
the thymus, reduction in the number of naïve T-cells
with a parallel increase of oligoclonaly expanded CD4+
T-cells with a memory phenotype, reduced potential to
produce IL-2 and loss of CD28 expression [15–17].
Adaptive immunity undergoes severe deterioration with
age and this represents the main problem in the elderly.
However, evidence accumulated over the last decade
supports the hypothesis that ageing has also a profound
impact on innate immunity, which in turn markedly in-
fluences health and longevity of older people [3, 18–20].
In the complex scenario of immunosenescence, it has
been generally accepted that some aspects of innate im-
munity, e.g., phagocytosis and natural killer (NK)-cell
cytotoxicity, remain largely unaffected [19–21]. Innate
immune responses are more resistant to change and
NK-cells are well preserved in healthy elderly subjects.
In fact, there is an age-related increase in CD16+ CD57-
cells with high cytotoxicity capacity. This increase in NK
cells has been correlated with successful ageing [21–24].
Our group reported a significant increase in frequency
of CD16+ IFN-γ+ NK-cells in aged individuals in schis-
tosomiasis endemic areas of Brazil who were protected
from schistosome infection. Therefore, a high frequency
of IFN-γ+ NK-cells correlated with “healthy ageing” in
endemic areas [22].
Studies in aged mice showed functional decline of mono-
cytes and macrophages, low expression level of Toll-like re-
ceptors from activated splenic and peritoneal macrophages
and altered secretion of several chemokines and cytokines
[25, 26]. Reduced class II major histocompatibility in aged
macrophages also contribute to impaired proliferative re-
sponse of activated peripheral T-lymphocytes [20, 27–29].
In humans, it has been described that although the
elderly preserve the number and phagocytic capacity of
neutrophils, other functional characteristics of these cells
such as superoxide anion production, chemotaxis, and
apoptosis are reduced during ageing [18, 30, 31].
In this sense, healthy immunosenescence is the net
result of a continuous adaptation of the body to deteri-
orative changes occurring over time. According to this
concept, body resources are continuously optimized, and
successful immunosenescence must be considered a very
dynamic process of immunological remodeling [32, 33].
Most of the studies investigating the influence of
inflammageing in the elderly were obtained at particular
age intervals and most of them come from Caucasian
individuals from either Europe or the United States.
Even among these reports, authors have observed varia-
tions and contrasting results as their samples vary demo-
graphically and geographically [34–36]. The study of
various age groups should yield more meaningful data
on immunosenescence that could be directly used by the
geriatricians to restore or attenuate deregulated immune
responses and assure a healthy longevity.
In this study, we described age-related changes in the
frequency of cytokine-producing leukocyte populations
in order to contribute to the establishment of new refer-
ence parameters for Brazilian individuals.
Methods
Aim of the study
The aim was to establish new reference parameters of
cytokine production by leukocytes for Brazilian healthy
individuals at different ages. Since there are controver-
sies on the topic of cytokine production during ageing
due to differences in experimental designs [37], this
study is part of a broad effort to identify cell subsets
involved in the production of distinct patterns of
cytokines during healthy ageing.
Study population
The study population consisted of 181 healthy subjects:
35 children, 22 adolescents and 124 adults (age range
0–85 years). Blood samples were obtained from children
visiting clinics for routine pediatric inspection. Adult sam-
ples were obtained from healthy individuals who accepted
to participate in the study. Subjects were divided into 6
age categories: Newborn – 0 years (n = 12); Children – 6 –
10 years (n = 23); Adolescent – 11 – 20 years (n = 22);
Adults – 21–50 (n = 80); Middle Aged – 51–60 (n = 22);
Elderly – 61–85 (n = 22). These age ranges were set based
on the main physiological changes occurring during life-
time (birth, childhood, adolescence, young and middle
adulthood, senescence) as well as similar patterns of
variation observed for cytokine-producing innate cells
(Additional file 1: Figure S1) and lymphocytes (Additional
file 2: Figure S2) throughout life. These volunteers were all
residents in the state of Minas Gerais (Southeast Brazil).
All individuals were interviewed by a health practi-
tioner using a health questionnaire, submitted to a phys-
ical exam and to hematological and biochemical tests to
establish their health condition. The exclusion criteria
for both populations were: infections, acute or chronic
inflammation, autoimmune diseases, heart disease,
undernourishment, anemia, leucopoenia, mood disor-
ders, neurodegenerative disease, neoplasias and use of
hormones (steroids) and drugs (alcohol, antidepressants,
immunosuppressants, anticoagulants). Children were
excluded of the study if they showed any evidence of
congenital disease, infection, immunological disorder or
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were taking any concomitant medications. Written
informed consent forms were obtained from each par-
ticipant, their parents or guardians prior to their inclu-
sion in our study. This work was approved by the
Ethical Committees of FIOCRUZ (Ministry of Health,
Belo Horizonte, Brazil) as well as the National Research
Ethics Committees (CONEP) of Brazil.
Blood collection
Nine milliliters (9 mL) of blood were drawn from each
individual always in the morning period to avoid circa-
dian variations.
Short-term whole blood culture and intracytoplasmic
cytokine staining
Aliquots of 500 μL peripheral blood were placed in 5
mL polypropylene tubes containing 500 μl RPMI-1640
added and incubated for six hours at 37 ºC and 5% CO2.
Next, 10 μL Brefeldin A (BFA; Sigma Chemical Com-
pany, St. Louis, MO) (10 mg/mL final concentration)
was added and incubated for four hours at 37 ºC and 5%
CO2. Then, 110 μL ethylenediamine tetraacetic acid
20 mM (EDTA; Sigma Chemical Company), (final con-
centration of 2 mM) solution was added. Tubes were in-
cubated for 15 min at room temperature. Next, 4 mL
PBS-W (cell wash solution) was added and samples were
centrifuged for 10 min at 400 x g and 18 ºC. Superna-
tants were collected and aliquots stained with
fluorescent-labeled anti-human cell surface monoclonal
antibodies (to CD4, CD8, CD14, CD16 and CD19) for
30 min at room temperature and protected from light.
After membrane staining, erythrocyte lysis, and leuko-
cytes fixation, cell suspensions were permeabilized with
PBS-P (PBS 0.05M pH 7.4 containing 0.5% BSA, 0.1%
sodium azide and 0.5% saponin: SIGMA, St. Louis, MO,
USA) and aliquots incubated for 30 min at room
temperature, in the dark, with fluorescent-labeled anti-
cytokine monoclonal antibodies to IL-4, IL-5, IL-10,
TNF-α and IFN-γ (BD-Pharmingen, San Jose, CA). After
intracytoplasmic cytokine staining, leucocytes were
washed with PBS-W and fixed in fixative solution Macs
Facs Fix (MFF). Samples were analyzed by flow cytome-
try for the production of TNF-α, IFN-γ, IL-4, IL-5 and
IL-10 by CD4+ T-cells and CD8+ T-cells, and the pro-
duction of TNF-α, IL-4 and IL-10 by CD19+ B cells.
Additionally, production of TNF-α, IFN-γ, IL-4 and IL-
10 by neutrophils, production of TNF-α and IL-10 by
monocytes and production of TNF-α, IFN-γ and IL-4 by
NK-cells were analyzed.
Flow cytometry acquisition and analysis
Flow cytometry acquisition and analysis were performed
in a FACScalibur™ equipped with a four-color detection
system (Becton Dickinson, San Jose, CA, USA), using the
CELLQUEST software (Franklin Lakes, NJ, USA). After
acquiring 30,000 events/tube, distinct gating strategies
were used to analyze the different cytokine-expressing
leukocytes subsets, including innate immune cells (neu-
trophils, monocytes and NK-cells) and adaptive immune
cells (CD4+, CD8+ T-cell subsets and B-cells). Selective
analysis of neutrophils was performed by establishing a
specific scatter gate using the dot plot distribution of anti-
CD16-FITC and laser side scatter (SSC) to discriminate
the neutrophils as SSC high CD16high+. Analysis of
monocytes was performed using the dot plot distribution
of anti-CD14-TC and SSC to discriminate the monocytes
as SSC int CD14high+ cells. Selection of NK-cells, T-cell
subsets and B-cells was performed by gating lymphocytes
on forward scatter (FSC) versus SSC dot plot distribution,
followed by analysis based on anti-CD16-FITC, anti-
CD19-FITC, anti-CD8-FITC or anti-CD4-TC labelling.
Following the selection of leucocyte subsets, frequency of
cytokine positive cells was determined using quadrant
statistics over FL-1/anti-cell surface marker-FITC or FL-3/
anti-cell surface marker-TC versus FL-2/anti-cytokine-PE
dot plot distribution. Results were expressed as percent-
ages of cytokine positive cells for different gated leucocyte
subpopulations analyzed.
Cytokine signature analysis
Cytokine-mediated immune response elicited by leuko-
cytes in each age group was assessed after short-term in
vitro culture with no stimulation. Analysis of the intracy-
toplasmic cytokine profile of peripheral blood leukocytes
initially yielded the percentage of cytokine positive cells.
Cytokine profiles produced by leukocytes were assessed
to identify low (≤ global median) and high (>global me-
dian) frequencies of cytokine-producing cells using the
global median of each cytokine as a cut-off. For the cal-
culation of the global median the whole universe of data
obtained for the groups was considered. Leukocyte sub-
populations assessed included neutrophils (NEU), mono-
cytes (MON), NK-cells as well as lymphocyte subsets
and the global median of each sub-population was de-
scribed in Table 1. This strategy allows multiple compara-
tive analyzes among groups, neither of which is excluded
from the analysis. The high frequency of cells producing
cytokines was used to evaluate the overall cytokine pat-
terns from healthy individuals categorized by age ranges.
Comparative data analysis
The type of analysis that we have used in the present
investigation is not a conventional statistical analysis.
This novel concept of cytokine signature has been pro-
posed by Luiza-Silva and colleagues [38]. It is a new
strategy to evaluate the overall cytokine profile instead
of analyzing single cytokine profiles. To reinforce our
data we also used the Spearman correlation test in our
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relevant findings. The immune profile is represented as
percentage of individuals with high frequency of cytokine-
producing innate and acquired immune cells. Relevant dif-
ferences were considered when the percentage of individ-
uals with a high frequency of cells producing a given
cytokine emerged above the 50th percentile (Figs. 1 and
2). This approach showed to be acurate to detect subtle
changes in cytokine signatures not detectable by conven-
tional statistical approaches. Then, considering the rele-
vant production of cytokines, Spearman correlation was
performed to evaluate increase or decrease in frequency of
cytokine-producing cells among age groups.
Since lymphocytes are known to be at higher numbers
in newborn and children than in adults, the absolute
numbers of lymphocytes for each age group is provided
in Table 2. In spite of the variation in the number of
these cells, cell frequencies are reliable parameters to
evaluate the relative contribution of each cytokine-
producing cells within a population.
Radar charts
Radar charts were used to summarize the proinflamma-
tory (▄) versus regulatory ( ) cytokine signatures in a
range of leukocyte subsets of innate and adaptive im-
munity for each age group. This analysis highlights the
contribution of different leukocytes subsets for the glo-
bal balance of cytokines. On radar charts, each axis rep-
resents the percentage (%) of volunteers showing high
frequency of cytokine-producing cells. The values of
each axis can be connected to form a central polygonal
area that represents the proinflammatory versus regula-
tory global balance. Increase or decrease of the central
polygonal area reflects either a higher or a lower contri-
bution of proinflammatory versus regulatory profile for
each age group.
Ascendant cytokine profile
The high cytokine producing-cell strategy was also used
to create, for each age group, an ascendant profile that
allows to analyze the hierarchical behavior of cytokine-
producing immune cells throughout life. For this
analysis, a functional cytokine categorization was used:
Inflammatory cytokines – red bars (TNF-α and IFN-γ)
and regulatory cytokines – blue bars (IL-4, IL-5 and IL-
10). Only those that had more than 50% frequency of
cytokine-producing cells in the group were considered
as relevant.
Results
To address the question of how ageing influences the
global profile of cytokine production by acquired and
innate immune cells, healthy individuals were catego-
rized in carriers of either low or high frequency of
cytokine-producing cells as previously described by
Luiza-Silva and co-workers [38]. This allowed calcula-
tion of the percentage of individuals with high fre-
quency of cytokine-producing cells for each age group.
To assess a functional cytokine profile, we classified
cytokines as proinflammatory (TNF-α and IFN-γ) and
regulatory (IL-4, IL-5 and IL-10) according to its func-
tional characteristics during the ageing process. We took
into account for this classification that Th1 cytokines
(TNF-α and IFN-γ) were mostly involved in chronic in-
flammatory disorders associated with ageing (such as car-
diovascular, autoimmune and degenerative diseases) [39–
41]. In addition, cytokines such as IL-4, IL-5.and IL-10
usually predominate in tolerogenic compartments such as
gut mucosa and maternal-fetal interface [42–44].
There are distinct variations in frequency of cytokine-
producing leukocyte subsets throughout life
To overview the production of proinflammatory and regu-
latory cytokines throughout life, we performed an evalu-
ation of the cytokine profile produced by leukocyte subsets
from the innate (neutrophils, monocytes and NK-cells) and
adaptive (CD4+ T-cells, CD8+ T-cells and B-cells) immune
compartments. In this analysis, individuals were categorized
Table 1 Global median of the universe of data on cytokine-
producing leukocytes
Immune Compartment Cytokine-producing leukocytes Median (%)









Acquired TNF-α+ CD4+ T-cells 0.28
IFN-γ+ CD4+ T-cells 0.26
IL-4+ CD4+ T-cells 0.32
IL-5+ CD4+ T-cells 0.11
IL-10+ CD4+ T-cells 0.75
TNF-α+ CD8+ T-cells 0.34
IFN-γ+ CD8+ T-cells 0.28
IL-4+ CD8+ T-cells 0.27
IL-5+ CD8+ T-cells 0.14





Silveira-Nunes et al. Immunity & Ageing  (2017) 14:2 Page 4 of 14
ab
Fig. 1 (See legend on next page.)
Silveira-Nunes et al. Immunity & Ageing  (2017) 14:2 Page 5 of 14
as carriers of either low or high frequency of cytokine-
producing cells, using the global median as a cut-off as
previously described [38]. Therefore, it was possible to
calculate the percentage of individuals with high frequency
of cytokine-producing cells for each age group.
As mentioned in the methods section, establishment
of age groups was performed according to the rhythmic
variation of cytokine-producing cells from both innate
and acquired immune compartments of peripheral blood
of individuals throughout life (Additional file 1: Figure S1
and Additional file 2: Figure S2). Overall distribution of
cytokine+ neutrophils, monocytes (CD14+) and NK-cells
(CD16+) (Additional file 1: Figure S1) and of cytokine+ T-
cells (CD4+ and CD8+) and B-cells (CD19+) (Additional
file 2: Figure S2) were plotted as a function of age (ranging
from 0 to 85). Age ranges were established based on the
overall variation rhythm observed, considering the moving
mean of all cytokine+ cell subsets (continuous lines). A
similar strategy was used previously by our group in a
study analyzing rhythmic variations in the frequency of
different subsets of peripheral blood monocytes in individ-
uals from 0 to 86 years of age. These age groups were
shown to represent a homogenous profile suitable to
identify immunologically meaningful periods in life [34].
Of note, in the innate cytokine profile, there was
the significant decrease of TNF-α-producing neutro-
phils from childhood to adulthood when it reached a
plateau. IFN-γ and IL-4 decreased early in life until
childhood. On the other hand, IL-10-producing neu-
trophils increased during adulthood (adult and middle
aged individuals). TNF-α-producing monocyte fre-
quency increased from birth until childhood, then,
maintained high during adolescence and adulthood
decreasing in the elderly. Interestingly, monocytes
maintained a low frequency of IL-10-producing cells
during early life and shifted towards a progressive
high production from adulthood to senescence. IFN-
γ-producing NK-cells and IL-4-producing NK-cells
increased in frequency from adult and middle-aged
groups, respectively, until senescence (Fig. 1).
Frequency of TNF-α-producing CD4+ T-cells had an
increase during the ageing process (significantly from
adulthood to senescence), while TNF-α-producing CD8+
T-cells and B-cells decreased their frequencies.
Regarding IFN-γ production, only CD4+ T cells changed:
they increased from adulthood to middle age. It could
be observed a significant decrease of IL-4-producing
CD8+ T cells throughout life (specially from adolescent
to elderly groups). An interesting pattern could be found
in the profile of IL-5-producing T-cells. At birth, there
was a high frequency of both IL-5-producing CD4+ T-
cells and CD8+ T-cells; then, these frequencies de-
creased during childhood to increase again in adoles-
cence, being maintained at approximately 50% of
frequency of high cytokine-producing cells during adult-
hood. From the fiftieth decade of life to senescence, the
frequency of IL-5-producing CD4+ and CD8+ T-cells in-
creased further. A remarkable finding is that all IL-10-
producing lymphocytes (T and B-cells) had their fre-
quency decreased from adolescence to senescence
(Fig. 2).
Profiles of high frequencies of proinflammatory- and
regulatory-cytokine-producing cells in innate and adaptive
immune compartments vary throughout life
To further characterize the cytokine pattern of healthy
individuals at distinct age groups, we have constructed
radar charts for high frequency of cells producing proin-
flammatory and regulatory cytokines and an ascendant
graph to characterize the hierarchical contribution of
cytokine-producing cell types to the cytokine profile of
each age group (Figs. 3 and 4).
Our data demonstrate that the cytokine pattern of
newborns was characterized by a prominent participa-
tion of proinflammatory responses of the innate im-
mune compartment (Fig. 3), especially driven by TNF-α
and IFN-γ from neutrophils (Fig. 4). This profile seems
to be counter-balanced by the presence of high frequen-
cies of cells producing regulatory cytokines (mostly IL-5-
producing T-cells) (Figs. 3 and 4).
According to our data, neutrophils had an important
role in childhood. These innate cells, together with mono-
cytes, produce large amounts of TNF-α, while neutrophils
also produced high levels of IL-10, creating a compensa-
tory circuit of cytokines (Figs. 3 and 4).
In the adolescent (11 to 20 years), we could observe a
shift in the composition of the cytokine profile. In this
age group, there was a predominance of adaptive
(See figure on previous page.)
Fig. 1 Profile of subjects with high frequency of neutrophils, monocytes and NK-cells producing proinflammatory and regulatory cytokines. a The
cytokine profile is presented as percentage of individuals with high frequency of cytokine-producing cells in each age group: Newborn – 0 years
(n = 12); Children – 6–10 years (n = 23); Adolescent – 11–20 years (n = 22); Adults – 21–50 (n = 80); Middle Aged – 51–60 (n = 22); Elderly – 61–85
(n = 22). Bars represent the percentage of subjects with high frequency of neutrophils producing tumor necrosis factor (TNF)-α, interferon
(IFN)-γ, interleukin (IL)-4 and IL-10, monocytes producing TNF-α and IL-10, and NK-cells producing TNF-α, IFN-γ and IL-4. Relevant differences
were considered when the percentage of individuals with high frequency cells producing a given cytokine emerged above the 50th percentile
(continuous line). Spearman correlation was performed to evaluate either increase or decrease in frequency of cytokine-producing cells among
age groups. Significant positive or negative correlations were represented by dotted arrows (↑). b Spearman’s rank correlation. Corresponding
Pearson’s correlation coefficient (r) and p value between cytokine-producing cell frequency and age in years is shown
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immune responses, with participation of proinflamma-
tory cytokines such as TNF-α from T and B-cells, and
IFN-γ from CD4+ and CD8+ T-cells with a contribution
of regulatory cytokines such as IL-4, IL-5 and IL-10 pro-
duced by T and B lymphocytes. Innate immune cells also
influence the adolescent profile: TNF-α and IFN-γ pro-
duced by neutrophils and NK-cells, as well as IL-4 pro-
duction by NK-cells (Figs. 3 and 4).
Interestingly, adults presented a profile well balanced
between innate and adaptive immune responses with an
equal contribution of proinflammatory and regulatory
cytokine-producing cells (Figs. 3 and 4).
Another shift in the composition of the cytokine pattern
could be observed from the fiftieth decade of life on.
Middle aged group changed their profile from a balanced
(seen in adulthood) to a higher contribution of the innate
compartment of immune cells. Middle aged groups
showed a high frequency of neutrophils producing TNF-α,
IL-4 and IL-10, of monocytes producing TNF-α and IL-10,
and of NK-cells producing IFN-γ. A prominent inflamma-
tory profile of cytokines produced by lymphocytes was also
observed in this age group (TNF produced by CD4+ T-
cells and B-cells, IFN-γ produced by CD4+ T-cells and IL-
4 produced by CD4 +T-cells and B-cells) (Figs. 3 and 4).
Changes in the cytokine pattern in the elderly group were
characterized by a balanced profile with a prominent con-
tribution of the innate immune response (driven by IL-10-
producing monocytes, IL-4-producing neutrophils, TNF-α-
and IFN-γ-producing neutrophils and NK-cells). Although
innate immune cells are the most relevant element in the
cytokine profile of this age group, the contribution of
adaptive immune cells could still be identified as IL-5- and
TNF-α-producing T-cells and IL-4-producing CD4+ T-
cells.
Discussion
Ageing influences the entire physiology of an organism,
resulting in changes on functions at the molecular, cellular
and systemic levels. Age-related physiological changes are
well characterized in the immune system, which is con-
tinuously remodeled over the life course. One of these
main remodeling changes during ageing occurs in the
network of cytokine production [4, 8, 45].
In this study, we evaluated the profile of cytokine pro-
duced by major peripheral blood cells of individuals
from various age groups. Interestingly, we observed that
ageing was not associated with a progressive decline in
cytokine production by all leukocyte subsets but it was
rather characterized by distinct fluctuations of cytokines
produced at various time points during a lifetime period.
Furthermore, these variations were distinctive of each
cell population examined.
Studies in this area are scarce and results are often
contradictory. It is difficult to compare data among vari-
ous studies owing to differences in experimental designs
[37]. According to some reports, an increase of the
plasma level of a variety of cytokines, in particular pro-
inflammatory cytokines and their soluble receptors, oc-
curs during ageing [2, 5, 7]. In this regard, it has to be
considered that the production of most cytokines is not
confined to one cell type and thus it is difficult to iden-
tify the cellular sources that contribute to their plasma
levels [46–48]. The technique of intracellular cytokine
staining [49] offers the possibility of evaluating the con-
tribution of different cells to the production of cytokines
in heterogeneous cell populations. Using this technique,
it was possible to measure intracellular cytokines and
cell surface markers simultaneously to identify specific
subpopulations of human leukocytes and to characterize
their cytokine production [50–55].
We evaluated the cytokine pattern of adaptive immune
cells (CD4+ T-cells, CD8+ T-cells and B-cells), consider-
ing that this arm of the immune system is specially tar-
geted during ageing. As expected, some cytokines, such
as IL-10 produced by T-cells declined with ageing.
(See figure on previous page.)
Fig. 2 Profile of subjects with high frequency of CD4+ T-cells, CD8+ T-cells and B-cells producing proinflammatory and regulatory cytokines. a
Cytokine profile is presented as percentage of individuals with high frequency of cytokine-producing cells in each age group: Newborn – 0 years
(n = 12); Children – 6–10 years (n = 23); Adolescent – 11–20 years (n = 22); Adults – 21–50 (n = 80); Middle Aged – 51–60 (n = 22); Elderly – 61–85
(n = 22). Bars represents the percentage of subjects with high frequency of CD4 T-cells producing tumor necrosis factor (TNF)-α, interferon (IFN)-γ,
interleukin (IL)-4, IL-5 and IL-10. CD8 T-cells producing TNF-α, IFN-γ, IL-4, IL-5 and IL-10. B-cells producing TNF-α, IFN-γ, IL-4, IL-5 and IL-10. Relevant
differences were considered when the percentage of individuals with high frequency of cells producing a given cytokine emerged above the
50th percentile (continuous line). Spearman correlation was performed to evaluate either increase or decrease in frequency of cytokine-producing cells
among age groups. Significant positive or negative correlations were represented by dotted arrows (↑). b Spearman’s rank correlation. Corresponding
Pearson’s correlation coefficient (r) and p value between cytokine-producing cell frequency and age in years is shown
Table 2 Number of lymphocytes in peripheral blood of individuals
from each age group
Age groups Total lymphocytes (mean + SD)a
Newborn 2848 + 1725
Children 2984 + 1310
Adolescent 2180 + 678
Adult 2270 + 753
Middle aged 2553 + 658
Elderly 1324 + 515
aNumbers represent the total lymphocytes + standard deviation for each age
group. Numbers of lymphocytes were obtained by blood count using an
Abbott Cell-Dyn 1700 automatic analyzer
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However, production of TNF-α and IFN-γ by CD4+ T-
cells and IL-5 produced by both CD4+ and CD8+ T-
cells were unaffected. Our group demonstrated that the
frequencies of T cells changes during ageing with max-
imum frequencies at the beginning of adulthood (19–40
years) and decreasing until elderly age. This is particu-
larly observed for CD4+ T-cells. In contrast, the fre-
quency of CD8+ T-cells is well preserved during ageing
declining only in individuals at 41–65 and 61–75 age
ranges [34]. Results obtained by Alberti and coworkers
[8] from the analysis of 47 European subjects at different
ages indicated that the percentage of IFN-γ+-positive
CD4+ T-cells significantly decreased in old and nona-
genarian individuals in comparison with young subjects
while the percentage of TNF-α-positive activated/mem-
ory CD4+ T-cells significantly decreased in old subjects
in comparison with young ones. Differences on the
methodology, age ranges and genetic background of the
population studied could explain these distinct findings.
Immunosenescence studies in humans have mainly
focused on the impairment of the T-cell compartment.
However, changes are not limited to T-cells; B-cells have
been studied as well. These cells showed a decreased
production of TNF-α and IL-10 in adults and in the eld-
erly group [12, 56, 57]. Our group has observed that fre-
quencies of B-cells decline in Brazilian individuals of
19–40 age group and these data is compatible with the
lower percentage of cytokine-positive B-cells in adult-
hood [34].
Although changes in T and B-cell functions were
identified in healthy elderly, innate immune responses
seem to be more resistant to age-associated changes
[1]. NK-cells are one of the cellular mediators of innate
defense and have been extensively studied in the eld-
erly. The number and cytotoxicity activity of NK-cells
are increased in healthy elderly and centenarians.
Moreover, cumulative evidence in the last two decades
supports the importance of NK-cell activity in main-
taining good health during ageing. This is consistent
with the well-preserved NK-cell cytotoxicity in cente-
narians fitting other criteria of healthy status such as
physical fitness, independence to perform daily
Fig. 3 Radar graph representing the balance of subjects with high frequency of inflammatory (▄) or regulatory ( ) cytokine-producing cells of
innate and adaptive immunity. Graphs were constructed with each axis displaying the proportion of subjects with high frequency of cytokine-
producing cells within a given leukocyte subset. The values of each axis can be joined to form the central polygon area that represents the
general inflammatory/regulatory cytokine balance. Increasing or decreasing central polygon areas reflects either higher or lower contribution of
inflammatory versus regulatory cytokine balance in each age group. Analysis of the radar chart axes highlights the contribution of distinct
leukocyte subset for the overall cytokine balance. Age groups were categorized as: Newborn – 0 years (n = 12); Children – 6–10 years (n = 23);
Adolescent – 11–20 years (n = 22); Adults – 21–50 (n = 80); Middle Aged – 51–60 (n = 22); Elderly – 61–85 (n = 22)
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activities, or adequate cognitive function [18, 21, 23, 24].
Our group reported a significant increase in frequency of
CD16+ IFN-γ+NK-cells in non-infected individuals who
inhabit schistosomiasis endemic areas of Brazil, and these
cells are maintained at higher frequency in subjects over
70 years old. This suggests that the healthy individuals
(who remain non-infected in endemic areas) are those
who sustain a high frequency of IFN-γ+ NK-cells as
they age [22]. In accordance with that, our results dem-
onstrated that healthy ageing was related to a higher
frequency of NK-cells that produce both a type 1 (IFN-γ)
cytokine, and a counterbalancing type 2 (IL-4) cytokine.
Other innate immune cells seem to have a role in the
immune-senescence process. Cellular components of the
innate immune system, including neutrophils and
macrophages, are the first to arrive at the site of injury.
Their role is to initiate an inflammatory response,
phagocyte the pathogen (in case of infection), recruit
NK-cells, and facilitate the maturation and migration of
dendritic cells (DCs) that regulate and determine the na-
ture of the T-cell-mediated outcome [18]. Interestingly,
frequencies of TNF-α-, IFN-gamma- and IL-4-producing
neutrophils decreased from birth to adulthood and were
maintained until senescence. On the other hand, fre-
quency of TNF-α+ monocytes had a high plateau at
childhood and decrease only at senescence. Of note, at
this life stage, the reduced frequency of IL-10 production
by adaptive immune cells was counter-balanced by an
increase in the frequencies of IL-10+ cells from the in-
nate compartment (neutrophils and monocytes).
Fig. 4 Signature of high frequency of cytokine producing-cells from innate and adaptive immune compartments by individuals of different
age groups. Age groups were characterized as: Newborn – 0 years (n = 12); Children – 6–10 years (n = 23); Adolescent – 11–20 years (n = 22);
Adults – 21–50 (n = 80); Middle Aged – 51–60 (n = 22); Elderly – 61–85 (n = 22). Ascendant frequency of cytokine-producing cells from innate
and adaptive immune compartments in each group was represented by bars. Red bars represent inflammatory-cytokine-producing cells and
the blue bars represent regulatory-cytokine-producing cells. Dotted line represent the 50th percentile that was used as a cut-off to identify
relevant differences
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Production of cytokines and their sources should not
be evaluated alone during a complex process such as
immunosenescence. The immune response is the result
of several events that involves recruitment of cells, pro-
duction of cytokines and chemotactic factors, establish-
ment of immunoregulatory and proinflammatory factors.
In this context, we performed a cytokine profile to assess
a global picture of the immune response during the age-
ing process. This kind of analysis took into account the
importance of the environment to an efficient immune
response. This alternative strategy has been used by our
group in a previous study [38], and it proved to be a
useful tool to understand some of the complex immuno-
logical changes occurring during ageing.
Another important aspect of this study was the inclu-
sion of a group of children. The childhood represents a
critical period of immune development and there is a
lack of data on the distributions of immunological
parameters in healthy children [58]. We demonstrated
that newborns had a high frequency of IL-5-producing
T-cells, while neutrophils producing type 1 cytokines
predominated in the innate immune compartment, a
profile that remained in children. Exposure to an in-
creasingly diverse range of antigens during the first years
of life could be responsible for the environmentally
driven type 1 response observed in the childhood period
[59, 60]. These changes seem to promote a healthier im-
mune profile, considering that failure in suppressing
exacerbated type 2 immune responses and decreased
capacity in producing type 1 cytokines during infancy
are characteristic of individuals prone to develop allergic
diseases [59–61].
Adolescents (11 to 20 years of age) presented an im-
munological profile characterized by balanced frequencies
of adaptive cells able to produce both proinflammatory
and regulatory cytokines. Adequate exposure to envir-
onmental antigens during infancy and the rise in sex
hormones could explain the change into a robust and
balanced immune profile with a predominant contri-
bution of cytokine-producing adaptive immune cells
in these individuals.
The immune system reached equilibrium in adult-
hood, when the cytokine profile was characterized by a
balance contribution of innate and adaptive compart-
ments to the production of both inflammatory and
regulatory cytokines. Observing the overall cytokine
production in individuals from the 25–51 age (Middle
Aged) group, one could notice that it can be already
observed a decline in cytokine production by adaptive
immune cells and an expansion of the contribution of
innate cells to cytokine secretion. It is widely accepted
that T cells are specially targeted during immunosenes-
cence. A number of factors have been linked to the
decline in T-cell function with ageing. Age-related
thymic atrophy, decreased output of naïve T-cells and
the resulting memory-type oligoclonal T-cell repertoire
are of particular importance. All these changes are pro-
gressive and start at different time points of adulthood
[15–17, 33].
As individuals age, major immunological events such
as T-cell activation and cytokine production are pro-
gressively altered. Interestingly, in all analyses per-
formed, the elderly group presented a balanced profile
between regulatory and proinflammatory cytokines,
with a prominent contribution of innate immune cells
to this balance. Our results support the hypothesis that
healthy immunosenescence involves remodeling and
adaptation to the changes started in adulthood and ag-
gravated by ageing [32, 33].
Conclusions
Taken together, our results showed a distinct pattern of
changes in cytokine production by different leukocyte
subsets during ageing. Furthermore, healthy ageing in
this Brazilian population seems to involve alternative
mechanisms to maintain an appropriate balance between
regulatory and proinflammatory responses with well-
preserved innate immunological activities compensating
the impaired adaptive immune response at senescence.
The present study has limitations that should be
acknowledged. First, we did not used Body Mass Index
(BMI), body composition or nutritional behavior for
this analysis, due to the unavailability of tools at the
time of blood collection. Second, a small number of in-
dividuals was used preventing a definitive proposal of
these profiles as representative of Brazilian individuals
in general. One positive aspect about our cohort, how-
ever, is that the individuals are from the state of Minas
Gerais, which is considered by demographic standards
the most representative of the Brazilian population
[62]. Therefore, despite the limitations, this study pre-
sents also important strengths. It is the first report de-
scribing changes in the profile of cytokine-producing
leukocytes in Brazilian individuals within a large
spectrum of age (0–85 years). These findings are an ex-
tension of another study from our group [34] that ana-
lyzed the frequency of sub-populations of leukocytes in
Brazilian individuals at similar age range (0–85 years).
Data presented here may help to establish immuno-
logical reference values for future studies in Brazilian
individuals at all ages. Longitudinal studies may reveal
in more detail the role of innate immune cells in the
elderly. Due to the progressive increase in the aged
population in Brazil, these studies are critical for de-
sign and implementation of public policies aimed to
optimize immune function and to improve the quality
of life at advanced age.
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Additional file 1: Figure S1. Representative scatter distribution of
cytokine-producing cell subsets from the innate immunity compartment of
peripheral blood. Overall distribution of cytokine + neutrophils, monocytes
(CD14+) and NK-cells (CD16+) was plotted as a function of age (ranging
from 0 to 85). Age ranges were established based on the overall variation
rhythm observed, considering the moving mean of all cytokine+ cell subsets
(continuous lines). The selected age ranges were referred as: Newborn – 0 years;
Children – 6–10 years; Adolescent – 11–20 years; Adults – 21–50 years; Middle
Aged – 51–60 years and Elderly – 61–85 years. Dashed rectangles were used to
confine data into each established age range. (PDF 264 kb)
Additional file 2: Figure S2. Representative scatter distribution of
cytokine-producing cell subsets from the adaptive immunity compartment
of peripheral blood. The overall distribution of cytokine + T-cells (CD4+ and
CD8+) and B-cells (CD19+) was plotted as a function of age (ranging from 0
to 85). Age ranges were established based on the overall variation rhythm
observed, considering the moving mean of all cytokine + cell subsets
(continuous lines). The selected age ranges were referred as: Newborn – 0 years;
Children – 6–10 years; Adolescent – 11–20 years; Adults – 21–50 years; Middle
Aged – 51–60 years and Elderly – 61–85 years. Dashed rectangles were used to
confine data into each age range established. (PDF 333 kb)
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